These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36642706)

  • 21. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
    Zheng P; Li N; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
    Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
    Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
    Pi Y; Sun F; Zhang Z; Liu X; Lou G
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
    Fei H; Han X; Wang Y; Li S
    J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer.
    Chen SF; Wang LY; Lin YS; Chen CY
    J Ovarian Res; 2024 Sep; 17(1):190. PubMed ID: 39342345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of tumor endothelial cells (TEC) in gastric cancer and development of a TEC-based risk signature using single-cell RNA-seq and bulk RNA-seq data.
    Fan M; Xu X; Hu Y
    Aging (Albany NY); 2024 Jun; 16(12):10252-10270. PubMed ID: 38870270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Data to Explore the Key Role of Fatty Acid Metabolism in Breast Cancer.
    Chen Y; Wu W; Jin C; Cui J; Diao Y; Wang R; Xu R; Yao Z; Li X
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
    Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
    Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.
    Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y
    Front Immunol; 2022; 13():894718. PubMed ID: 35812403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.
    Zheng M; Hu Y; Liu O; Li S; Wang Y; Li X; Liu J; Yang Q; Li X; Lin B
    Oxid Med Cell Longev; 2023; 2023():1261039. PubMed ID: 36743693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer.
    Zhu L; Lin Z; Wang K; Gu J; Chen X; Chen R; Wang L; Cheng X
    Front Endocrinol (Lausanne); 2024; 15():1372413. PubMed ID: 38529390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.
    Liu Y; Liu S; Yan L; Zhang Q; Liu W; Huang X; Liu S
    Mediators Inflamm; 2023; 2023():1400267. PubMed ID: 38022687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
    Duan Y; Xu X
    Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer.
    Zhao S; Zhang X; Gao F; Chi H; Zhang J; Xia Z; Cheng C; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1145797. PubMed ID: 36950684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated analysis of single-cell RNA-seq and bulk RNA-seq to unravel the molecular mechanisms underlying the immune microenvironment in the development of intestinal-type gastric cancer.
    Su Y; Zhang X; Liang Y; Sun J; Lu C; Huang Z
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166849. PubMed ID: 37591405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
    Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
    Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
    Zhu K; Ma J; Tian Y; Liu Q; Zhang J
    BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
    Xiang SY; Li QK; Yang Z; Yi Q
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.